Third World

Posted By on September 1, 2018

Diseases for which at the moment effective treatments like malaria exist, AIDS; or meningitis, could be fought if the patients had access to medecines, access prevented by the prices of the licenses. The private company is forced to its shareholders having sold the medecine development. As well as nobody accuses the manufacturers of foods when there is extreme hunger in some place of Africa, the partnerships are shielded in which it takes responsibility to them of the sanitary problems of the planet. And like target of the critic, the legal actions against the partnerships increase to day to day also causing the failure of new licenses to commercialize medecines " tiles". Reason for joy? It does not stop the patients.

While the detrimental medecine risk is reduced, also the hope to cure its diseases. sets out the reality of the pharmaceutical product business, indicating, that one hundred transnational companies with an international market of 300 000 million dollars block the generic medecine sales that can be acquired to prices much more cheap by the poor countries to the benefit of their settlers. That mercantilista and enriching policy of the pharmaceutical companies hits the intention and practice of many nations of the Third World that try to cure and to stop diseases or pandemics like the Syndrome of Acquired Immunodeficiency (AIDS). Those medecines, by their high prices, are difficult to acquire in great amounts by the erosion that they cause to the fragile economies of those states. When having those companies the patents of the immense majority of medicines available in the international market, prohibit by means of a complicated frame of laws that scientific institutions of to other can produce them nations and commercialize. The generic medicine account with the same active principle, formulates pharmaceutics and the composition of the original product and therefore can be acquired more cheap. .

About the author


Comments are closed.